Chongqing Sintaho Pharmaceutical Co., Ltd. (hereinafter called “Sintaho”), founded in 2016, is a leading Active Pharmaceutical Ingredient (API) enterprise with distinctive characteristics, perfect GMP supporting systems, and long-time GMP compliance. Sintaho has full chain operation capabilities spanning R&D, production, registration, domestic and international marketing of APIs. Over the years, Sintaho has been honored with numerous titles, including National High-tech Enterprise, National Specialized and Sophisticated “Little Giant” firm, Chongqing Enterprise Technology Center, and Chongqing Hazardous Waste Management Benchmark Enterprise.
Sintaho's predecessor was"Chongqing Taihao Pharmaceutical Co.,Ltd. "Over the course of many years of development, it has cultivated a core management team with rich experience in R&D, Quality, Production, and Regulatory. The team has extensive experience in passing audits and inspections by domestic and international drug regulatory authorities such as NMPA, FDA, EDQM, and PMDA.
Sintaho focuses on three primary business segments: High-potency/Cytotoxic APIs, Peptides, and XDC Compounds, and is able to provide sophisticated CDMO and CMO services to our global partners by owning the dedicated cytotoxic API production lines, OEB5-level high-potency API production lines, and peptide production lines.
Sintaho is driven by its mission to “produce high-quality medicines to serve human health” and upholds core values of “people-oriented integrity, professional rigor, and innovative development.” It is dedicated to becoming a trusted API supplier in the global pharmaceutical supply chain.
Sintaho strictly controls the environment,,
health and safety (EHS) to ensure its safety,
environmental and health compliance through regular internal and external audits.
Sintaho fully implements and strictly follows cGMP and ICH guidelines.
The quality management team has rich experience on inspections of NMPA,
US FDA, EDQM, PMDA and other authorities.
日前,由重庆医药化工联合会主办,重庆兴泰濠制药有限公司承办的“青春‘篮’不住·友谊不止步”篮球友谊赛在重庆国际生物城成功举行,大家携手并肩迎“篮”而上,为友谊而战,为友谊喝彩!此次篮球友谊赛在去年圆满
日前,重庆兴泰濠制药有限公司(简称“兴泰濠”)再传捷报,顺利通过美国食品药品监督管理局(FDA)首次现场审计。2024年8月下旬,FDA检查官对兴泰濠原料药阿扎胞苷及公司整体的生产质量管理体系进行了为
“液相色谱分析中,当某物质的浓度与响应值呈正比例关系,测定含量宜采用的方法是什么,请答题。”近日,在重庆兴泰濠制药有限公司首届“技能大比武”决赛现场,来自QC、生产技术部、生产车间的员工,组成四支混编
日前,全国第六批专精特新“小巨人”企业名单公布,重庆兴泰濠制药有限公司(简称“兴泰濠”)作为重庆市入选名单中唯一制药企业,喜获该项殊荣!专精特新企业是国家为鼓励中小企业实现专业化运营、精细化产出、特色